Influence of clinical-immunobiological factors on efficiency of antipsychotic therapy with olanzapine in patients with schizophrenia

Abstract

SUMMARY:
Objective: The study of clinical and immunobiological factors in patients with schizophrenia with different efficacy of olanzapine treatment.
Patients and Methods. The study includes 29 inpatients with the verified diagnosis of schizophrenia (according to ICD:10) treated at the clinics of Mental Health Research Institute for
exacerbation with response to therapy with olanzapine in the period of previous hospitalization. The assessment of degree of severity of symptoms and changes in the dynamics of the therapy
with olanzapine is carried out by week 6 of the treatment with use of clinical scales PANSS, CGI. Laboratory methods include identification of parameters of cellular, humoral, phagocytic links
of the immunity and concentration of cortisol in blood serum.
Results. The most expressed features of the immune status in the group of patients with high efficiency of the therapy in comparison with the group of patients with low efficiency of the
treatment before administering the psychopharmacotherapy are higher values of the number of T:helpers/inducers (CD4+), natural cells:killers (CD16+) and cortisol level. The same patients
have a high total score according to PANSS.
Conclusions. A complex of clinical:immunobiological parameters associated with the effect of the antipsychotic therapy is revealed that can be considered during differentiated administering
the antipsychotic for heightening the efficiency of the conducted therapy